Show simple item record

dc.contributor.authorOtienoburu, SD
dc.contributor.authorMaïga-Ascofaré, O
dc.contributor.authorSchramm, B
dc.contributor.authorJullien, V
dc.contributor.authorJones, JJ
dc.contributor.authorZolia, YM
dc.contributor.authorHouzé, P
dc.contributor.authorAshley, EA
dc.contributor.authorKiechel, JR
dc.contributor.authorGuérin, PJ
dc.contributor.authorLe Bras, J
dc.contributor.authorHouzé, S
dc.date.accessioned2016-09-15T15:13:07Z
dc.date.available2016-09-15T15:13:07Z
dc.date.issued2016-09-05
dc.date.submitted2016-09-12
dc.identifier.citationSelection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. 2016, 15:452 Malar. J.en
dc.identifier.issn1475-2875
dc.identifier.pmid27596849
dc.identifier.doi10.1186/s12936-016-1503-3
dc.identifier.urihttp://hdl.handle.net/10144/618654
dc.description.abstractPlasmodium falciparum uncomplicated malaria can successfully be treated with an artemisinin-based combination therapy (ACT). However resistance is spreading to the different ACT compounds; the artemisinin derivative and the partner drug. Studies of P. falciparum polymorphisms associated with drug resistance can provide a useful tool to track resistance and guide treatment policy as well as an in-depth understanding of the development and spread of resistance.
dc.language.isoenen
dc.publisherBioMed Central (Springer Science)en
dc.rightsPublished by BioMed Central, [url]http://www.malariajournal.com/[/url] Archived on this site by Open Access permissionen
dc.titleSelection of Plasmodium Falciparum pfcrt and pfmdr1 Polymorphisms After Treatment with Artesunate-Amodiaquine Fixed Dose Combination or Artemether-Lumefantrine in Liberiaen
dc.identifier.journalMalaria Journalen
refterms.dateFOA2019-03-04T12:50:26Z
html.description.abstractPlasmodium falciparum uncomplicated malaria can successfully be treated with an artemisinin-based combination therapy (ACT). However resistance is spreading to the different ACT compounds; the artemisinin derivative and the partner drug. Studies of P. falciparum polymorphisms associated with drug resistance can provide a useful tool to track resistance and guide treatment policy as well as an in-depth understanding of the development and spread of resistance.


Files in this item

Thumbnail
Name:
Otienoburu et al - 2016 - Selection ...
Size:
1.032Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record